RF vs VIR
RF (RF) versus Vir Biotechnology Inc (VIR) — a side-by-side from cached financials, not a winner call.
RF (RF) common stock.
Vir Biotechnology Inc (VIR) is a biotechnology company listed on NASDAQ.
RF does not have a complete income-statement cache yet.
Latest reported VIR revenue for 2024-12-31 was $74.2M. Net income was -$522.0M. Revenue was down 13.9% from 2023-12-31 to 2024-12-31. VIR currently screens at market cap $1.45B.
RF currently screens at market cap $0. VIR currently screens at market cap $1.45B.
Not investment advice. Open the RF and VIR stock pages for the full models.
Not investment advice.